FDA Inspection
Contacare Ophthalmics & DiagnosticsContacare Ophthalmics & Diagnostics – FDA Inspection, Apr 29, 2013
Record Details
This FDA Inspection record concerns Contacare Ophthalmics & Diagnostics, with an inspection on April 29, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 29, 2013
- Product Type
- Drugs
View Company Profile
ID · 11d4e6f7-0669-4d50-8bb3-1fcfe375f8ba
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 832888
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
19- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
- 21 CFR 211.160(a)Deviations from laboratory control requirements
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.194(d)Laboratory equipment calibration records
- 21 CFR 211.194(a)(8)Second person sign off
Showing 10 of 19 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Contacare Ophthalmics & Diagnostics
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 1, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 4, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Contacare Ophthalmics & Diagnostics
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.